Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab
Nom du journal : Gut
Année : 2019
Volume : doi: 10.1136/gutjnl-2018-316407 [Epub ahead of print]